YUMANITY THERAPEUTIC

YMTX
Delayed Quote. Delayed  - 10/20 04:00:00 pm
9.13USD +5.31%

Turn to zoom
Prev.8.6700
Open8.6600
High9.5300
Low8.4800
Volume95 728
Latest news
6d ago
09/09
09/09
08/16
Chart YUMANITY THERAPEUTICS, INC.
Financials
Sales 2021 9,48 M - -
Net income 2021 -48,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,98x
Yield 2021 -
Capitalization 94,1 M 94,1 M -
Capi. / Sales 2021 9,92x
Capi. / Sales 2022 9,51x
Nbr of Employees 45
Free-Float 86,6%
Company
Yumanity Therapeutics Inc., formerly Proteostasis Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. The Company's technology platform enables the rapid screening...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
No events available

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 9,13 $
Average target price 36,67 $
Spread / Average Target 302%